FI95247B - Förfarande för framställning av som läkemedel användbara -karbonylkarboxiamider av 1,3-tiazolidiner - Google Patents

Förfarande för framställning av som läkemedel användbara -karbonylkarboxiamider av 1,3-tiazolidiner Download PDF

Info

Publication number
FI95247B
FI95247B FI904512A FI904512A FI95247B FI 95247 B FI95247 B FI 95247B FI 904512 A FI904512 A FI 904512A FI 904512 A FI904512 A FI 904512A FI 95247 B FI95247 B FI 95247B
Authority
FI
Finland
Prior art keywords
formula
thiazolidine
methoxyphenoxymethyl
compound
compounds
Prior art date
Application number
FI904512A
Other languages
English (en)
Finnish (fi)
Other versions
FI904512A0 (sv
FI95247C (sv
Inventor
Carmelo Gandolfi
Domenico Roberto Di
Silvano Spinelli
Licia Gallico
Bruno Lumachi
Sergio Tognella
Original Assignee
Boehringer Mannheim Italia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim Italia filed Critical Boehringer Mannheim Italia
Publication of FI904512A0 publication Critical patent/FI904512A0/sv
Publication of FI95247B publication Critical patent/FI95247B/sv
Application granted granted Critical
Publication of FI95247C publication Critical patent/FI95247C/sv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/14Antitussive agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/04Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Electric Double-Layer Capacitors Or The Like (AREA)
  • Carbon And Carbon Compounds (AREA)
  • Hydrogenated Pyridines (AREA)

Claims (4)

1. Förfarande för framställning av som läkemedel användbara /9-karbonylkarboxiamider av 1,3-tiazolidiner med formeln I: 5 ro' s—| JL ^ O - CH " , % (of 2 ^ ? (I) där: R är väte, C1-C4-alkyl; 15 RjärCj-C^alkyl, Cj-C^alkoxi, hydroxi, Cj-C^alkylamino, 2-(dietylamino)etylamino, 4-metylpiperazin-l-yl, 4-bensylpiperazin-l-yl och α-, β- tai γ-pyridylmetylamino; kännetecknat därav, att man läter en förening med formeln II 20 RO I/O - CH 25 ® 2 H där R är defmierad som ovan, reagera med en förening med formeln III 30 R! CO-CH2-COOH (III) eller med ett akti vt derivat, 95247 där Rj har samma betydelser som ovan, eller dA sA önskas kan föreningen enligt formeln I som firamställts pA ovan presenterat sätt ändras pA i och för sig känt sätt tili en annan forening med formeln I pA sAdant sätt, att gruppen Rt ändras och vid behov, bildas ett sait och/eller ett soivat av föreningen med formeln I och/eller separas S stereoisomerer av föreningama enligt formeln I.
2. Förfarande enligt patentkrav 1, kännetecknat därav, att R är metyl.
3. Förfarande enligt patentkrav 1 eller 2, kännetecknat därav, att Rj väljs 10 frän en grupp som bestär av metyl, etoxi, hydroxi, metylamino (CH3NH-), dietylamino- etylamino, 4-metyl-piperazino.
4. Förfarande enligt nägot av patentkraven 1-3 för framställning av en förening med formeln I, där Rt är metyl, kännetecknat därav, att den aktiverade arten av 15 syran CH3-C0CH2C02H är diketen. ··« 1 *« t . J·!
FI904512A 1988-03-17 1990-09-13 Förfarande för framställning av som läkemedel användbara -karbonylkarboxiamider av 1,3-tiazolidiner FI95247C (sv)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
IT8819813A IT1216119B (it) 1988-03-17 1988-03-17 Beta_carbonil_carbossiamidi di 1,3_tiazolidine.
IT1981388 1988-03-17
PCT/EP1989/000205 WO1989008648A1 (en) 1988-03-17 1989-03-02 beta-CARBONYL-CARBOXYAMIDES OF 1,3-THIAZOLIDINES
EP8900205 1989-03-02

Publications (3)

Publication Number Publication Date
FI904512A0 FI904512A0 (sv) 1990-09-13
FI95247B true FI95247B (sv) 1995-09-29
FI95247C FI95247C (sv) 1996-01-10

Family

ID=11161493

Family Applications (1)

Application Number Title Priority Date Filing Date
FI904512A FI95247C (sv) 1988-03-17 1990-09-13 Förfarande för framställning av som läkemedel användbara -karbonylkarboxiamider av 1,3-tiazolidiner

Country Status (19)

Country Link
US (1) US5206254A (sv)
EP (2) EP0407403A1 (sv)
JP (1) JPH0688987B2 (sv)
KR (1) KR960011381B1 (sv)
AT (1) ATE95814T1 (sv)
AU (1) AU624124B2 (sv)
BG (1) BG60459B1 (sv)
CA (1) CA1325632C (sv)
DE (1) DE68909815T2 (sv)
DK (1) DK168486B1 (sv)
ES (1) ES2059595T3 (sv)
FI (1) FI95247C (sv)
HU (1) HU205920B (sv)
IT (1) IT1216119B (sv)
NO (1) NO179370C (sv)
RO (1) RO107656B1 (sv)
RU (1) RU1833378C (sv)
WO (1) WO1989008648A1 (sv)
ZA (1) ZA892014B (sv)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1245712B (it) * 1991-04-09 1994-10-14 Boehringer Mannheim Italia Ammine eterocicliche utili terapia dell'asma e dell'infiammazione delle vie aeree
IT1270594B (it) * 1994-07-07 1997-05-07 Recordati Chem Pharm Composizione farmaceutica a rilascio controllato di moguisteina in sospensione liquida
US6586466B2 (en) 1995-10-30 2003-07-01 Smithkline Beecham Corporation Carbohydrazide-protease inhibitors
US6083964A (en) * 1998-02-18 2000-07-04 K And K Biosciences, Inc. Optical resolution of racemic aminoalkylpyridine anticonvulsants and (+) aminoalkylpyridine enantiomers as highly potent orally effective anticonvulsant drugs and excitatory amino acid antagonists
WO2000030446A1 (en) 1998-11-23 2000-06-02 Bonnie Davis Dosage formulations for acetylcholinesterase inhibitors
CN1319955C (zh) * 2003-06-10 2007-06-06 浙江海正药业股份有限公司 莫吉斯坦晶型
WO2008144956A1 (fr) * 2007-05-28 2008-12-04 Tianjin Institute Of Pharmaceutical Research Nouveaux composés ambroxol, leurs procédés de préparation et leurs utilisations
EP2070915A1 (en) * 2007-12-03 2009-06-17 A.M.S.A. ANONIMA MATERIE SINTETICHE E AFFINI S.p.A. New process for the synthesis of moguisteine
CN102653527A (zh) * 2011-12-22 2012-09-05 东莞达信生物技术有限公司 一种莫吉司坦合成工艺

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU195492B (en) * 1984-07-27 1988-05-30 Boehringer Biochemia Srl Process for producing 2-substituted thiazolidine derivatives with antitussive and mucus regulating action and pharmaceuticals comprising these compounds as active ingredient
GB2164333B (en) * 1984-07-27 1988-11-16 Boehringer Biochemia Srl Antitussive and mucus regulating 2-substituted thiazolidines
IT1201489B (it) * 1985-11-13 1989-02-02 Chiesi Farma Spa Derivati di tiazolidina,loro procedimento di preparazione e formulazioni farmaceutiche
IT1228251B (it) * 1987-07-02 1991-06-05 Boehringer Biochemia Srl Amidi di amino-tioacetali ciclici, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono

Also Published As

Publication number Publication date
NO179370C (no) 1996-09-25
ES2059595T3 (es) 1994-11-16
IT1216119B (it) 1990-02-22
DK168486B1 (da) 1994-04-05
DK221490D0 (da) 1990-09-14
EP0407403A1 (en) 1991-01-16
KR960011381B1 (ko) 1996-08-22
DK221490A (da) 1990-09-14
EP0333080A1 (en) 1989-09-20
AU3189289A (en) 1989-10-05
HU205920B (en) 1992-07-28
RO107656B1 (ro) 1993-12-30
WO1989008648A1 (en) 1989-09-21
ATE95814T1 (de) 1993-10-15
AU624124B2 (en) 1992-06-04
JPH0688987B2 (ja) 1994-11-09
HU891559D0 (en) 1991-06-28
RU1833378C (en) 1993-08-07
CA1325632C (en) 1993-12-28
NO904031D0 (no) 1990-09-14
IT8819813A0 (it) 1988-03-17
JPH03504123A (ja) 1991-09-12
FI904512A0 (sv) 1990-09-13
BG60459B1 (bg) 1995-04-28
ZA892014B (en) 1989-11-29
US5206254A (en) 1993-04-27
FI95247C (sv) 1996-01-10
DE68909815D1 (de) 1993-11-18
DE68909815T2 (de) 1994-03-24
EP0333080B1 (en) 1993-10-13
HUT56355A (en) 1991-08-28
NO904031L (no) 1990-11-16
KR900700470A (ko) 1990-08-13
NO179370B (no) 1996-06-17

Similar Documents

Publication Publication Date Title
EP0757038B1 (en) Benzamide compound and medicinal use thereof
FI80020B (fi) L-n-n-propylpipekolsyra-2,6-xylidid och foerfarande foer dess framstaellning.
KR850000301B1 (ko) 페닐에탄올 아민 유도체의 제조 방법
RU2167152C2 (ru) N-замещенные азагетероциклические карбоновые кислоты или их фармацевтически приемлемые соли, способ их получения, фармацевтическая композиция на их основе и способ ингибирования нейрогенного воспаления
EP2283833A2 (en) Amines and amides for the treatment of diseases
AU4780699A (en) Farnesyl protein transferase inhibitors for treating arthropathies
EA014370B1 (ru) Циклопропиламины в качестве модуляторов рецептора гистамина н
JP4259615B2 (ja) 薬物常用および特にアルコール中毒の治寮へのγ―ヒドロキシ酪酸アミドの使用
EA002763B1 (ru) Альфа-аминоамидные производные, полезные в качестве анальгетических агентов
FI95247B (sv) Förfarande för framställning av som läkemedel användbara -karbonylkarboxiamider av 1,3-tiazolidiner
KR20010024220A (ko) 신규한 npy 길항제
WO1995011894A1 (en) Histamine h3-receptor antagonists and therapeutic uses thereof
KR100233489B1 (ko) 연동촉진성 벤즈아미드
JP2004502684A (ja) Comt阻害活性を有するクマリン誘導体
JP2650739B2 (ja) 分割化アミノピロリジン神経防護剤
DK172192B1 (da) Nye benzothiazepinderivater, fremgangsmåder til fremstilling deraf og farmaceutiske præparater
JPH03866B2 (sv)
KR20010024074A (ko) 이미다졸린 화합물
JP2006506402A (ja) 四級アンモニウム化合物およびその抗ムスカリン薬としての使用
RU2732417C1 (ru) Производные фенотиазина и способы их применения
JPH0692948A (ja) 新規なアセタミド誘導体及びその用途
BRPI0720665A2 (pt) S-nitrosotióis estáveis, método de síntese e uso.
WO1996008468A1 (en) Carbamoyloxy amine compounds
RU2233279C1 (ru) СОЛИ 9-ω-АРИЛОКСИАЛКИЛ-2,3-ДИГИДРОИМИДАЗО[1,2-А]БЕНЗИМИДАЗОЛА, ОБЛАДАЮЩИЕ МЕСТНОАНЕСТЕЗИРУЮЩИМ ДЕЙСТВИЕМ
JP5597400B2 (ja) ヒスチジン誘導体を含有する医薬

Legal Events

Date Code Title Description
BB Publication of examined application
FG Patent granted

Owner name: DOMPE INTERNATIONAL S.A.

PC Transfer of assignment of patent

Owner name: DOMPE INTERNATIONAL S.A.

MA Patent expired